TEST CATALOG ORDERING & RESULTS SPECIMEN HANDLING CUSTOMER SERVICE EDUCATION & INSIGHTS
Test Catalog

Test ID: IN16Q    
CBFB-MYH11 Inversion(16), Quantitative Detection and Minimal Disease Risk Monitoring, qRT-PCR, Varies

Useful For Suggests clinical disorders or settings where the test may be helpful

Detection of CBFB-MYH11 gene fusion in patients recently diagnosed with acute myeloid leukemia (AML)

 

Minimal residual disease monitoring during the clinical and therapeutic course of patients with AML

Highlights

This test is a highly sensitive quantitative assay for the detection of inv(16)(p13.1q22) or t(16;16)(p13.1;q22) CBFB-MYH11 gene fusion. This detection is useful for patients with acute myeloid leukemia (AML) at the time of diagnosis as well as for minimal residual disease monitoring during the clinical and therapeutic course of these patients.

Method Name A short description of the method used to perform the test

Quantitative Real-Time Reverse Transcription Polymerase Chain Reaction (qRT-PCR)

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

Inv(16); CBFB-MYH11, Quant, V

Aliases Lists additional common names for a test, as an aid in searching

Inv(16)
T(16;16)
Inv(16)(p13.1q22)
T(16;16)(p13.1;q22)
CBFB-MYH11
AML M4 Eo